Clinical Trial Update: Letrozole in Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the aromatase inhibitor letrozole for uterine leiomyosarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: GOG Foundation | Conditions: Uterine Leiomyosarcoma | Phase 2 | Status: RECRUITING